4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-046824
Chief Technology Officer sold 20,000 shares at $8.07 ($161,400)
- Chief Technology Officer gave up 3,640 shares (to pay taxes)
- Chief Technology Officer acquired 9,344 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yan Ming Chief Technology Officer | 2023-08-18 | Option exercise 10b5-1 | +1,981 | 7,832,239 | D | ||
| Yan Ming Chief Technology Officer | 2023-08-18 | Shares withheld for taxes 10b5-1 | −772 | $8.46 | $6,531 | 7,831,467 | D |
| Yan Ming Chief Technology Officer | 2023-08-18 | Option exercise 10b5-1 | +7,363 | 7,838,830 | D | ||
| Yan Ming Chief Technology Officer | 2023-08-18 | Shares withheld for taxes 10b5-1 | −2,868 | $8.46 | $24,263 | 7,835,962 | D |
| Yan Ming Chief Technology Officer | 2023-08-21 | Sale 10b5-1 | −20,000 | $8.07 | $161,400 | 7,815,962 | D |
| Derivatives | |||||||
| Yan Ming Chief Technology Officer | 2023-08-18 | Option exercise · Restricted Stock Units 10b5-1 | −1,981 | 19,161 | D | ||
| Yan Ming Chief Technology Officer | 2023-08-18 | Option exercise · Restricted Stock Units 10b5-1 | −7,363 | 105,542 | D | ||
| Open-market sales · 20,000 sh · avg $8.07 · $161,400 | |||||||
Loading xslF345X05/doc4.xml…